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INTRODUCTION
Dengue is an acute febrile illness that has a large clinical spectrum, ranging from unapparent infection, flulike mild undifferentiated fever and the classical dengue fever (DF) to the severe disease plasma-leakage syndrome known as dengue hemorrhagic fever (DHF) (Lee et al. 2006 ). The impact of dengue infection in public health and on the overall economy is not well defined, *These authors contributed equally in this work.
but it can be considered to be very high mainly in oping countries (Shu and Huang 2004) .
In the last years, we have been witness increasing amount of knowledge concerning d However, molecular aspects of the immune re triggered by dengue virus infection and pathog of the severe form of dengue are poorly unde (Sanches et al. 2005) owing to the lack of natu imal models that develop the disease (Bente and Hesse 2006). DHF most often occurs in seq dengue infection (Halstead et al. 1983 ). This is
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an exacerbated production of cytokines, activation of T-lymphocytes and insufficient clearance of apoptotic bodies. The correlation of disease severity with molecular markers of immune activation and other factors such as altered platelet, dendritic cells and monocytes counts, have suggested that immune responses of dengue viruses are contributing to autoimmune process that results in DHF (Halstead 2007) . There are currently no vaccines nor antiviral drugs available for dengue viruses and neither specific therapy for the prevention and treatment of the infection caused by dengue virus. However, early diagnostic and intervention with simple medical care, like hydration, is effective to significantly reduce the dengue mortality (Sanches et al. 2005, Shu and Huang 2004) .
One of the problems associated with dengue patient management is the early identification of which patients will develop DHF and will require hospitalization (Shu and Huang 2004) . The diagnosis of dengue virus infection is relatively simple and trustable, but the reliable prediction of which patients will develop severe vasculopathy and DHF is not currently possible. The diagnosis is usually made after the patients had already presented severe DHF symptoms. Therefore, a rapid differential DF/DHF diagnosis is crucial to proper patient triage. A prognosis test that allows foreseeing which patients will develop DHF during the acute febrile phase of the infection could permit the focus of the medical attention to be those patients identified as under high risk to develop the lethal disease and reduce unnecessary costly hospitalizations.
The development of genomics technology, microarray and high throughput quantitative PCR has allowed the study of all the transcriptomes and develop useful tools for the investigation of the simultaneous expression and interaction of thousands of genes. The comparison of the transcriptomes of patients that developed DF with those that developed DHF has provide an opportunity to identify molecular markers associated with immunity and symptomatology of the disease (Ubol et al. 2008, Kruif et al. 2008 ).
Here we investigate patterns of six differentially putatively candidates for molecular markers predictive of the hemorrhagic fever.
MATERIALS AND METHODS

PATIENTS
The study was performed on patients from an ongoing dengue cohort study carried out in 
Primer Express 2.0 software (Applied Biosystems, Foster City, CA, USA) was used to design sets of primers and probes. The design of six sets of primers and probes were performed following the same principle: only the mRNA should be amplified. To test the specificity of the primers, we performed conventional PCR assays using cDNA (400ng) obtained as described below, and also human genomic DNA (5ng -Invitrogen, Carlsbad, CA, USA) as control. The PCR reactions were made using the following parameters: 95 • C-15 s, 58 • C-60 s, 40 cycles, and primers 2, 5μM.
QUANTITATIVE REAL-TIME PCR
Genes were amplified and detected using TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA) with primers and probes designed as mentioned above. Total RNA was extracted using the RNeasy mini Kit (Qiagen, Valencia, CA, USA) and treated with DNAse (Qiagen, Valencia, CA, USA). Total RNA (1μg) was reversely transcribed to cDNA using SuperScript III First-strand Synthesis System (Invitrogen, Carlsbad, CA, USA) and random hexamer primers (Invitrogen, Carlsbad, CA, USA) following the reaction: 50 • C for 30 minutes, 85 • C for 5 minutes and chilled on ice. RNase H (2U) (Invitrogen, Carlsbad, CA, USA) was added and samples were incubated at 37 • C for 20 minutes. Quantitative real time PCR was carried out using the ABI PRISM 7500 device (Applied Biosystems, Foster City, CA, USA). Two mixes composed by eight DF/DFC or eight DHF cDNA samples were used as targets. A mix of five ND cDNA samples was used as a reference to DF and DHF results. β-Actin gene expression was used for the normalization of gene expression data due to the constitutive nature of its expression. The reactions were performed in triplicates and included 2μl of cDNA, primers (20μM each) and 6.25μM of the specific probe, hu- 
RESULTS
A set of primers were designed to specifically a the target genes from cDNA, but not from any c inant genomic DNA in the samples. For this pu it was chosen the junction regions of exons from genes and, for all of them, the primers or the was annealed in this region. To test the specifi the primers, we performed conventional PCR patient's extracted cDNA and human genomic D control. In Figure 1 it is possible to notice unique with the expected molecular weight indicating t the six sets of primers amplified correctly their r tive genes. To test the primers ability to ampl nomic DNA, we used human genomic DNA in th conditions of amplification. It is also possible serve that none of the primers specifically amplifi nomic DNA.
To verify the influence of infection by DENV expression of tested genes, we performed qPCR using a pool composed by five cDNA samples of individuals, and a pool composed by sixteen cDN ples obtained from PBMCs of DF and DHF patien the genes tested, previously identified by microar periments, were up-regulated after infection of p by DENV (Fig. 2) . The mRNA of each patient w lected during the acute febrile phase of disease (T
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CARLOS E. CALZAVARA-SILVA et al. lyses using pools composed by cDNA of health individuals, or by cDNA of DF patients, or by cDNA of expressed in DHF patients, whereas the other genes showed the opposite behavior. Among the six tested candidates, apparently genes 3 to 6 showed better capacity to discriminate DF and DHF. Like genes 3 and 6, gene 5 also shows a difference in its expression levels when comparing DHF and DF samples. It is interesting to note that gene 5 was the most expressed in DF samples among the tested genes.
DISCUSSION
Gene expression studies represent an opportunity to identify novel markers linked to immunity and disease pathogenesis, and an opportunity to classify patients with dengue in a manner that provides greater biological relevance and clinical utility (Fink et al. 2007 ). Nowadays, one of the most relevant questions to scientists concerning dengue symptomatology is to determine which factors have influence on the development of DHF. It is a consensus that the severity of dengue is associated to multifactorial aspects like viral charge and serotype, sequential infections and genetics aspects of the host (Simmons et al. 2007 ). predict the prognosis of DENV infected patients to develop the severe form of the disease.
Studies performed in cell lines or in patient's samples have been obliging to demonstrate gene expression associated with dengue infection. Kruif et al. (2008) showed the molecular basis of inflammatory gene expression patterns in peripheral blood leukocytes from children with severe dengue infection. It was demonstrated significant differences in gene expression patterns between DF PBMCs and DHF PBMCs during the acute phase of the infection.
In this work, we used a set of primers specifically designed to amplify cDNA, obtained from PBMC of DF and DHF patients, codifying for six genes involved on innate immune responses, previously identified by microarray approach, whose expression levels were different between the classical and severe forms of the has been shown a strong association between a dec innate immune response and increased apoptosis with the development of DHF (Kruif et al. 2008 , U al. 2008 , Simmons et al. 2007 Corroborating our data, the only gene more exp in DHF samples was gene 6 (Fig. 3) , a pro-ap gene. Gene 6 is almost 4-fold more expressed in d than in non-dengue samples. Otherwise, all the five genes tested, involved on innate immune resp were up regulated in DHF patients.
The involvement of apoptosis on the develo severe symptoms noticed in DHF was earlier stud Mongkolsapaya et al. (2003) , when they recover dengue-responsive CD8+ T cells in Thai children acute phase of disease; most of those undergoin grammed cell death. In fact, during the last yea correlation between the apoptosis process and h
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In our study, gene 5, which is more directly involved on innate immune responses, since its product codify for a receptor to the Fc portion (FcR) of immunoglobulin, was the most down regulated in DHF samples among the five tested genes, corroborating the findings of other research groups (Kruif et al. 2008 , Ubol et al. 2008 , Simmons et al. 2007 , Chaturvedi et al. 2006 . However, the expression levels of gene 5 presented the highest standard deviation values, indicating that the level of expression of this gene could be very variable among patients and, consequently, inappropriate do be used alone as "DHF molecular signature".
Recently, Brown et al. (2009) had demonstrated that antibody-enhanced dengue virus infection of the FcR-bearing mast cell/basophil KU812 cell line results in a massive induction of caspase-dependent apoptosis. This find corroborates the relationship of the expression levels of genes 5 and 6.
The qPCR assay results indicates that the quantification of those genes in samples collected during the early symptoms of a dengue infected patient could be useful on the prognosis of DHF development. The identification of a group of genes with potential to be used as molecular signatures of DHF development can become a confident tool, valuable in helping on DHF clinical diagnosis. Our results suggest that it is possible to define the genes that are differentially expressed between DF and DHF patients during the initial moments of the onset of symptoms and, consequently, predict the propensity of a dengue patient to evolve to the severe form of the disease. However, it is necessary to increase the number of samples to statistically determine the reliability limits of these results.
Nowadays we are collecting more samples of dengue-infected patients in the acute phase of the disease to reinforce data presented here and also to be used on tests of predictive value, specificity and sensibility. Moreover, we are selecting other genes to be tested aiming to define the best panel of "DHF molecular signature genes". O painel de candidatos a marcadores de prognóstico obtido demonstrou um bom potencial para uso clínico na forma de um ensaios rápido baseado em amostras de sangue.
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